Human Interaction Network Ontology

Last uploaded: June 27, 2014
Preferred Name

L-ornithine
Synonyms

(S)-2,5-Diaminopentanoic acid

InChIKey=AHLPHDHHMVZTML-BYPYZUCNSA-N

(S)-2,5-Diaminopentanoate

(S)-2,5-diaminovaleric acid

NCCC[C@H](N)C(O)=O

C5H12N2O2

(S)-alpha,delta-diaminovaleric acid

(S)-ornithine

InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1

L-Ornithine

L-ornithine

(2S)-2,5-diaminopentanoic acid

Definitions

An optically active form of ornithine having L-configuration.

ID

http://purl.obolibrary.org/obo/CHEBI_15729

database_cross_reference

KEGG COMPOUND:70-26-8

CiteXplore:22133808

KEGG COMPOUND:C00077

Gmelin:327282

DrugBank:DB00129

Wikipedia:Ornithine

Reaxys:1722298

KEGG DRUG:D08302

CiteXplore:19173225

ChemIDplus:1722298

CiteXplore:22387109

PDBeChem:ORN

CiteXplore:19083482

ChemIDplus:70-26-8

HMDB:HMDB00214

CiteXplore:22735334

CiteXplore:22033378

MetaCyc:ORNITHINE

CiteXplore:18676473

CiteXplore:17190852

CiteXplore:15576628

definition

An optically active form of ornithine having L-configuration.

has_alternative_id

CHEBI:13148

CHEBI:21367

CHEBI:6280

has_exact_synonym

L-Ornithine

L-ornithine

(2S)-2,5-diaminopentanoic acid

has_obo_namespace

chebi_ontology

has_related_synonym

(S)-2,5-Diaminopentanoic acid

InChIKey=AHLPHDHHMVZTML-BYPYZUCNSA-N

(S)-2,5-Diaminopentanoate

(S)-2,5-diaminovaleric acid

NCCC[C@H](N)C(O)=O

C5H12N2O2

(S)-alpha,delta-diaminovaleric acid

(S)-ornithine

InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1

id

CHEBI:15729

imported from

http://purl.obolibrary.org/obo/chebi.owl

label

L-ornithine

notation

CHEBI:15729

prefixIRI

CHEBI:15729

prefLabel

L-ornithine

subClassOf

http://purl.obolibrary.org/obo/CHEBI_33704

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_15729 FYPO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 OBA SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 DINTO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 DTO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 GO-PLUS SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 BERO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 BIOMODELS SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 CHEBI SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 NIFSTD SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 ONSTR SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 FYPO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_15729 FYPO LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 OBA LOOM
http://purl.bioontology.org/ontology/RCD/XaDdV RCD LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 DTO LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 GO-PLUS LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 ONSTR LOOM
http://purl.obolibrary.org/obo/CHEBI_15729 FYPO LOOM
http://www.drugbank.ca/drugs/DB00129 FTC LOOM
http://purl.obolibrary.org/obo/IMR_0200342 HOIP LOOM
http://purl.obolibrary.org/obo/IMR_0200342 TXPO LOOM
http://purl.obolibrary.org/obo/UPa_UPC00077 UPA LOOM